SPINK1 protein binds to EGFR and activates its downstream signals, leading to the progression of pancreatic cancer, prostate cancer, bladder cancer (BCa), pancreatic ductal adenocarcinoma and breast cancer cells (Figure 1) (79–83). This evidence concerns the gene SPINK1 and prostate cancer.